Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1373317 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
The hit-to-lead optimization of the HNE inhibitor 5-methyl-2-(2-phenoxy-pyridin-3-yl)-benzo[d][1,3]oxazin-4-one is described. A structure–activity relationship study that focused on the 5 and 7 benzoxazinone positions yielded the optimized 5-ethyl-7-methoxy-benzo[d][1,3]oxazin-4-one core structure. 2-[2-(4-Methyl-piperazin-1-yl)-pyridin-3-yl] derivatives of this core were shown to yield HNE inhibitors of similar potency with significantly different stabilities in rat plasma.
Graphical abstractThe synthesis, inhibitory activity, hydrolytic stability, and rat plasma stability of 2-pyridin-3-yl-benzo[d][1,3]oxazin-4-one based inhibitors of human neutrophil elastase are described.Figure optionsDownload full-size imageDownload as PowerPoint slide